Skip to content
10-Q

Quarterly Report

Yubo International Biotech Ltd YBGJ

0001640334-23-001530

← back to feed
Filed
Aug 11, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 4, 2023 119.82M sh
Capex Q2 2023 · Jun 30, 2023 $0
Capex Q2 2023 · Jun 30, 2022 $0
Cash And Equivalents Q2 2023 · Jun 30, 2023 $5.3K
Stockholders Equity Q2 2023 · Jun 30, 2023 −$1.15M
Stockholders Equity Q2 2023 · Mar 31, 2023 −$838.76K
Stockholders Equity Q2 2023 · Dec 31, 2022 −$565.37K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$1.25M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$760.12K
Stockholders Equity Q2 2023 · Dec 31, 2021 −$131.2K
Current Liabilities Q2 2023 · Jun 30, 2023 $2.95M
Current Liabilities Q2 2023 · Dec 31, 2022 $2.52M
Total Liabilities Q2 2023 · Jun 30, 2023 $3.11M
Total Liabilities Q2 2023 · Dec 31, 2022 $2.91M
Current Assets Q2 2023 · Jun 30, 2023 $700.59K
Current Assets Q2 2023 · Dec 31, 2022 $750.01K
Total Assets Q2 2023 · Jun 30, 2023 $1.96M
Total Assets Q2 2023 · Dec 31, 2022 $2.35M
Operating Cash Flow Q2 2023 · Jun 30, 2022 $33.34K
Net Income Q2 2023 · Jun 30, 2022 −$491.56K
Net Income Q2 2023 · Jun 30, 2022 −$1.07M
Net Income Q2 2023 · Mar 31, 2022 −$578.95K
Operating Income Q2 2023 · Jun 30, 2022 −$491.5K
Operating Income Q2 2023 · Jun 30, 2022 −$1.07M
Gross Profit Q2 2023 · Jun 30, 2022 $5.85K
Gross Profit Q2 2023 · Jun 30, 2022 $14.12K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $2.12K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $9.07K
Revenue Q2 2023 · Jun 30, 2022 $7.97K
Revenue Q2 2023 · Jun 30, 2022 $23.18K